Índice

• • ·Editorial board

    Página :i

    

• Éditoriaux/ Editorials

  • ·Bismuth and pharmacovigilance

    Página :383-384

    Thierry Trenque

    Esquema Esquema
  • ·Adverse drug reaction monitoring: Doing it the French way – Act II

    Página :385-387

    Thomas Soeiro, Clémence Lacroix, Joëlle Micallef

    Esquema Esquema

• Droit médical/ Medical right

  • ·Le Comité de protection des personnes (CPP), carrefour des quiproquos

    The Committee for the Protection of Human Subjects in biomedical research, crossroads of misunderstandings

    Página :389-402

    Jean-Paul Demarez

    Resumen Resumen Esquema Esquema

• Pharmacologie clinique / Clinical pharmacology

  • ·Quality of evidence of the efficacy of therapeutic interventions on patient-important outcomes in Cochrane's systematic reviews’ abstracts: A survey

    Página :403-408

    Christine Maynié-François, Benoît Tudrej, Elodie Tawil, Florian Naudet, Caroline Huas, Denis Pouchain, Hélène Vaillant-Roussel, Nemat Jaafari, Rémy Boussageon

    Resumen Resumen Esquema Esquema  

• Pharmacocinétique /Pharmacokinetics

  • ·Observed concentrations of amikacin and gentamycin in the setting of burn patients with gram-negative bacterial infections: Preliminary data from a prospective study

    Página :409-414

    Silvia Corcione, Amedeo De Nicolò, Tommaso Lupia, Francesco Vladimiro Segala, Anna Pensa, Riccardo Corgiat Loia, Maria Rosa Romeo, Giovanni Di Perri, Maurizio Stella, Antonio D’Avolio, Francesco Giuseppe De Rosa

    Resumen Resumen Esquema Esquema
  • ·Alteration of the pharmacokinetics of aminoglycosides by adsorption in a filter during continuous renal replacement therapy. An in vitro assessment

    Página :415-424

    Frédéric J. Baud, Pascal Houzé, Pierre Carli, Lionel Lamhaut

    Resumen Resumen Esquema Esquema  

• Pharmacoépidemiologie/ Pharmacoepidemiology

  • ·Daily practices regarding safety monitoring of low-dose methotrexate and comparison to guidelines: A population-based cohort study

    Página :425-433

    Canelle Mazaud, Laurence Fardet

    Resumen Resumen Esquema Esquema
  • ·Patterns of quadruple therapy use including bismuth for Helicobacter pylori eradication: A cohort study in the French national claims database

    Página :435-440

    Patrick Blin, Magali Rouyer, Estelle Guiard, Frank Zerbib, Bertrand Diquet, Francis Mégraud, François Tison, Abdelilah Abouelfath, Régis Lassalle, Cécile Droz-Perroteau, Nicholas Moore

    Resumen Resumen Esquema Esquema   

• Pharmacovigilance/ Pharmacovigilance

  • ·The French pharmacovigilance surveys: A French distinctiveness, a real input

    Página :441-447

    Malak Abou Taam, Baptiste Jacquot, Claire Ferard, Anne-Charlotte Thery, Céline Mounier, Aurélie Grandvuillemin, Annie-Pierre Jonville-Béra, Marie-Christine Perault-Pochat, Réseau français des centres régionaux de pharmacovigilance

    Resumen Resumen Esquema Esquema  
  • ·TNF-? inhibitors and psychiatric adverse drug reactions in the spectrum of bipolar (manic) or psychotic disorders: Analysis from the French pharmacovigilance database

    Página :449-454

    Cécile Marie Yelnik, Louise Gaboriau, Nadine Petitpain, Hélène Théophile, Emmanuel Delaporte, Louise Carton, Sophie Gautier, Marc Lambert

    Resumen Resumen Esquema Esquema  
  • ·Profils d’effets indésirables sous abiratérone et enzalutamide : analyse descriptive des données de la base nationale de pharmacovigilance

    Adverse drug reactions profiles for abiraterone and enzalutamide: A pharmacovigilance descriptive analysis

    Página :455-465

    Lucie-Marie Scailteux, Clémence Lacroix, Sandrine Bergeron, Fabien Despas, Marion Sassier, Louise Triquet, Sylvie Picard, Emmanuel Oger, Elisabeth Polard, et le réseau français des Centres régionaux de pharmacovigilance

    Resumen Resumen Esquema Esquema   

• Thérapeutique/ Therapeutics

  • ·Adherence to biologic disease-modifying antirheumatic drugs in adult patients with rheumatic diseases

    Página :467-474

    Alia Fazaa, Yasmine Makhlouf, Amad Ben Ouhiba, Saoussen Miladi, Mariem Sellami, Kmar Ouenniche, Leila Souabni, Salma Kassab, Selma Chekili, Leith Zakraoui, Kawther Ben Abdelghani, Ahmed Laatar

    Resumen Resumen Esquema Esquema

• Lettres à la rédaction/ Letters to the editor

  • ·Drug-drug interactions between two beta-lactam antibiotics and valproic acid in the same patient

    Página :475-477

    Emna Gaies, Ikram Fazaa, Mouna Ben Sassi, Rim Charfi, Nadia Jebabli, Hanene El Jebari, Riadh Daghfous, Sameh Trabelsi

    Esquema Esquema  
  • ·Use of triptans during pregnancy? With caution!

    Página :477-478

    Isabelle Lacroix, Caroline Hurault-Delarue, Delphine Viard, Bruno Revol, Lemya Chaalel, Christine Damase-Michel

    Resumen Resumen Esquema Esquema
  • ·Warning on increased serious health complications related to non-medical use of nitrous oxide

    Página :478-479

    French Association of Addictovigilance Centres, Joelle Micallef, Michel Mallaret, Maryse Lapeyre-Mestre, Amélie Daveluy, Caroline Victorri-Vigneau, Hélène Peyrière, Danièle Debruyne, Sylvie Deheul, Régis Bordet, Cécile Chevallier, Marie-Christine Perault-Pochat, Reynald Le Boisselier, Frédéric Libert, Leila Chaouachi, Pierre Gillet

    Esquema Esquema
  • ·Cinderella side effect: Intravenous corticosteroid-induced bradycardia

    Página :480-481

    Matteo Coen, Peter Jandus, Victoria Rollason, Jörg Seebach, Jacques Serratrice

    Esquema Esquema  
  • ·Amlodipine and perindopril-induced hypertrichosis in a six-year-old girl: A case report

    Página :481-483

    Camille Azam, Geneviève Durrieu, Emilie Deuilhe, Margaux Lafaurie

    Esquema Esquema  
  • ·À propos d’un cas d’exacerbation sévère d’acouphènes lors d’un syndrome d’arrêt à la venlafaxine

    Tinnitus and venlafaxine discontinuation syndrome

    Página :483-486

    Guillaume Meyer, Alexis Erb, Bruno Michel, Coraline Hingray, Fabrice Duval, Hervé Javelot

    Esquema Esquema
  • ·Acute myocarditis during carboplatin and pemetrexed chemotherapy for lung adenocarcinoma

    Página :486-488

    Ferdaous Yangui, Ahmed Zaiem, Saoussen Antit, Syrine Bellakhal, Lilia Zakhama, Mohamed Ridha Charfi

    Esquema Esquema  
  • ·Réaction lors de la perfusion de dalbavancine : à propos d’un cas

    Reaction during dalbavancin infusion: About one case

    Página :488-490

    Benjamin Valentin, Julien Dartus, Teddy Trouillez, Louise Gaboriau, Caroline Loiez, Hervé Dezèque, Pascal Odou, Bertrand Décaudin, Henri Migaud, Stéphanie Genay, Eric Senneville

    Esquema Esquema
  • ·Effets indésirables de l’antimoniate de méglumine dans la leishmaniose cutanée chez le sujet âgé

    Adverse drug reactions of meglumine antimoniate in elderly patients with cutaneous leishmaniasis

    Página :490-494

    Fatma Hammami, Emna Bahloul, Rym Sahnoun, Khadija Sellami, Abderrahmen Masmoudi, Sonia Boudaya, Madiha Mseddi, Meriem Amouri, Kamilia Ksouda, Khaled Zghal, Hamida Turki

    Esquema Esquema
  • ·Patient's therapeutic education on renin-angiotensin system inhibitors could limit iatrogenic acute kidney injuries. The RASIzen study

    Página :494-497

    Charles Verney, Blueberry Pierrel, Arnaud Le Flécher, Juliette Oliary, Anthony Vanjak, Jacques Blacher, Gaël Ensergueix, Célia Lloret-Linares

    Esquema Esquema  
  • ·Severe polyuria secondary to acyclovir induced-proximal tubulopathy

    Página :498-499

    Elise Yvin, François Beloncle, Sylvain Thépot, Laurence Lagarce, Jean-François Augusto, Anne-Sophie Garnier

    Esquema Esquema
  • ·Possible apixaban-induced agranulocytosis: A life-threatening adverse drug reaction causing by a widely prescribed drug

    Página :499-500

    Patrick Chen, Michèle Zamy, Roya Nili-Asgari, Florence Cymbalista, Robin Dhôte, Sébastien Abad

    Esquema Esquema
  • ·From domperidone to metopimazine: Anticipating the media impact of pharmacovigilance announcements

    Página :500-501

    Michaël Rochoy, Camille Potey, Sophie Gautier, Johana Béné

    Esquema Esquema
  • ·Bismuth encephalopathy and mineral waters: a new hypothesis on bismuth absorption

    Página :502-504

    Hubert Déchy

    Esquema Esquema  
  • ·Vitiligo and anti-tumor necrosis factors: Cases report

    Página :504-507

    Nada Jaouad, Kawther Ben Abdelghani, Meriem Sellami, Fadoua Khadiri, Bouchra Amine, Imane Elbinoune, Alia Fazaa, Ahmed Laatar, Rachid Bahiri

    Esquema Esquema  
  • ·Training in medical hypnosis and prolonged use of benzodiazepines: The French national health insurance data

    Página :507-510

    Léa Légereau, Marion Bonnard, Johann Tétart, Adriaan Barbaroux

    Esquema Esquema  
  • ·A flare-up of rheumatoid arthritis followed by adrenocorticotropic insufficiency induced by pembrolizumab: A case-report

    Página :510-512

    Julie Garon-Czmil, Diane Abs, Florence Granel-Brocard, Pierre Gillet, Mélissa Yelehe-Okouma

    Esquema Esquema
  • ·Is caspofungin efficient to treat invasive candidiasis requiring continuous veno-venous hemofiltration? A case report

    Página :512-515

    Jean-Herlé Raphalen, Ambroise Marçais, Perrine Parize, Benoit Pilmis, Agnès Lillo-Lelouet, Lionel Lamhaut, Frédéric J. Baud

    Esquema Esquema

• Analyse d'ouvrage/ Book review

  • ·Bégaud B. La France malade du médicament : 110 milliards d’euros plus tard. Ed. de l’ObservatoireParis (2020). [192 pp. ISBN 979-10-329-0949-2]

    Página :516

    Jean-Louis Montastruc